Altitude Sickness: Clinical Trials

7 trials for Altitude Sickness, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 7 Phase 2, 3 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 27Completed 7
Phase 13Completed 3
Phase 31Completed 1

Follow Altitude Sickness: new trials by email Literature Review of Altitude Sickness trials Research Report on Altitude Sickness

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prochlorperazine Maleate Versus Placebo for the Prophylaxis of Acute Mountain Sickness
Prochlorperazine Maleate, Placebo - Acute Mountain Sickness
Phase 2CompletedUniversity of Colorado, Denver572024-08-052024-09-19
Safety and Efficacy of T89 in Prevention and Treatment of Adults With Acute Mountain Sickness (AMS)
T89 capsule, Placebo capsule - Acute Mountain Sickness (AMS)
Phase 2CompletedTasly Pharmaceuticals, Inc.1322018-06-072019-11-13
Study of Compound Danshen Dripping Pills to Treat Acute Mountain Sickness
Placebo, Compound danshen dripping pills - Acute Mountain Sickness
Phase 1 / Phase 2CompletedTasly Pharmaceuticals, Inc.582016-06-242017-09-01
Drug Combination on Exercise Performance at High Altitude
ambrisentan and theophylline, placebo - Acute Mountain Sickness
Phase 2 / Phase 3CompletedUniversity of Montana282013-08-012016-02-26
Study of Cobalt's Role in Excessive Erythrocytosis Among High Altitude Dwellers in Cerro de Pasco, Peru
N-acetylcysteine, Acetazolamide, Placebo pills - Erythrocytosis, Mountain Sickness
Phase 1 / Phase 2CompletedUniversity of Colorado, Denver852013-06-012015-05-15
Can Rhodiola Crenulata Intake Improve Oxygen Saturation and Decrease the Incidence of Acute Mountain Sickness
Rhodiola crenulata, placebo - Acute Mountain Sickness, Environmental Illness
Phase 2CompletedChang Gung Memorial Hospital1252010-10-012012-02-22
Prevention of High Altitude Pulmonary Edema
dexamethasone 8 mg bid, tadalafil 10mg bid - High Altitude Pulmonary Edema
Phase 1 / Phase 2CompletedUniversity of Zurich302003-07-012006-12-04

Narrower conditions

Environmental Illness (1)  ·  Polycythemia (1)

Broader conditions

Respiration Disorders (7)  ·  Respiratory Tract Diseases (7)  ·  Disorders of Environmental Origin (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hypersensitivity (1)  ·  Immune System Diseases (1)

Interventions

Acetazolamide (1)  ·  Acetylcysteine (1)  ·  BID protein, human (1)  ·  Dexamethasone (1)  ·  Gels (1)  ·  Prochlorperazine (1)  ·  Starch (1)  ·  Tadalafil (1)  ·  Theophylline (1)  ·  ambrisentan (1)

Sponsors

Tasly Pharmaceuticals, Inc. (2)  ·  University of Colorado, Denver (2)  ·  Chang Gung Memorial Hospital (1)  ·  University of Montana (1)  ·  University of Zurich (1)

Countries

United States (3)  ·  China (1)  ·  Peru (1)  ·  Taiwan (1)

Top investigators

Abdias Hurtado, MD (1)  ·  Elan Small, MD (1)  ·  Jeffrey W Sall, PhD, MD (1)  ·  Marco Maggiorini, MD (1)  ·  Min Zhao, PhD (1)  ·  Richard Fuquay, MD (1)  ·  Richard Johnson, MD (1)  ·  Te-Fa Chiu, MD (1)

Results publications

PMID 17015867, PMID 22829927, PMID 24176010, PMID 39574186